Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Fasenra Does Not Meet Primary Endpoint in Severe COPD Study

americanpharmaceuticalreviewMay 18, 2018

Tag: COPD , Primary Endpoint , FASENRA

PharmaSources Customer Service